Grünenthal and DKSH announce new partnership

28 September 2026

Singapore-based DKSH Business Unit Healthcare, a provider of market expansion services, has expanded its partnership with Germany’s pain management specialist Grünenthal.

Under the new regional agreement, DKSH will support the commercialization of four products from Grünenthal’s specialty pain portfolio in up to eight markets in Asia Pacific, namely Hong Kong, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, and Vietnam. The agreement marks the next phase of a successful partnership which previously covered three medicines from Grünenthal’s established portfolio, strengthening the commitment of both companies to improving access to holistic pain management solutions for patients across the region.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Company News Directory



More ones to watch >






Company Spotlight



More Features in Pharmaceutical